Pharma Pipelines, by the Numbers

Europe’s pharma pipeline disclosure is more detailed than in the U.S., where drugs in phase I trials are not always disclosed. This means counting the total number of drugs in development is more accurate in Europe.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.